New Recruiting Trial: Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
WHY IT MATTERS
This is the first Phase 1 trial testing preoperative radiation for recurrent adrenocortical carcinoma, offering eligible patients access to a potentially new treatment approach before it becomes widely available.
Researchers are looking for patients with a rare cancer called adrenocortical carcinoma that has come back after surgery. This study will test whether giving radiation therapy before surgery helps remove the cancer more effectively. The trial is just starting and will enroll patients beginning in April 2026.
NCT ID: NCT06487481 Title: Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma Status: RECRUITING Phase: PHASE1 Sponsor: National Cancer Institute (NCI) Start date: 2026-04-05 URL: https://clinicaltrials.gov/study/NCT06487481 Source: UniteRare clinical trials database